UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in EXEL — Exelixis, Inc.
CIK 861177
NEW YORK, NY
Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$65,363,109
+$9,948,507 QoQ
Shares Held
1,201,307
-7.0% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. EXEL ranks #14 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,363,109 | 1,201,307 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $55,414,602 | 1,292,017 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $28,739,895 | 655,713 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $31,041,613 | 751,613 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $50,076,419 | 1,136,035 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,234,168 | 845,996 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $28,116,683 | 844,345 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $21,033,533 | 810,541 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,456,836 | 865,903 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,678,235 | 618,552 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $14,886,392 | 620,525 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $13,435,933 | 614,917 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,714,666 | 560,684 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,882,873 | 560,684 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,839,881 | 551,115 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,273,017 | 527,616 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,430,743 | 597,058 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,816,462 | 521,238 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,111,754 | 498,455 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,822,550 | 464,643 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,262,935 | 508,394 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,047,682 | 489,052 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $10,515,613 | 523,947 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $9,360,850 | 382,857 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,838,542 | 372,306 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,903,786 | 458,989 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||